Research Areas
Active AI research
into neglected conditions.
Each thread is a live research investigation run by a swarm of specialized agents — mapping literature, finding analogies, stress-testing evidence, and surfacing findings the research system has left behind.
Research Gap Map — Uterine Fibroids
847 papers indexed · last scanned Mar 12, 2026Coverage bars show what fraction of 847 indexed papers address each research category. Gaps addressed by an active brief are linked below the bar.
5
Critical gaps
4
High-priority gaps
1
Zero-paper areas
3
Gaps with briefs
Vitamin D / ERβ interaction in fibroid tissue
CriticalDirect measurements of the Vitamin D – estrogen receptor β axis in fibroid or myometrial tissue.
↳ Zero papers test this pathway directly in fibroid tissue
Community-engaged study design
CriticalFibroid studies using CBPR (Community-Based Participatory Research) frameworks.
↳ Both published by the same research group; no replication
Black women in clinical trials
CriticalRandomised controlled trials with adequate Black enrollment (≥20% or pre-specified stratification).
↳ 2015–2025 window; none used community-based recruitment
Tissue-level biomarkers by race
CriticalStudies measuring molecular or protein-level differences in fibroid tissue between racial groups.
Race-stratified outcomes data
CriticalStudies that report outcomes broken down by race or ethnicity — onset age, severity, surgical results.
↳ 96.3% of indexed studies contain no race-stratified data
Race-stratified genomics & epigenetics
HighGWAS, methylation, or transcriptomic studies with race-stratified analysis.
Structural & environmental determinants
HighResearch modeling stress burden, chemical exposure (hair products, endocrine disruptors), or neighborhood effects alongside biological outcomes.
Surgical outcomes stratified by race
HighMyomectomy and hysterectomy outcome studies with race as a pre-specified variable.
↳ None used community-recruited cohorts; all single-institution
Quality-of-life measures in Black women
HighValidated QoL and symptom burden instruments applied to predominantly Black samples.
↳ Existing instruments validated on majority-white middle-class populations
Medical management efficacy by race
ModerateStudies of GnRH agonists, SPRMs, and other pharmacological treatments with race-stratified efficacy data.
Research Pipeline
Conditions queued for agent deployment. Gap scores reflect research underfunding relative to disease burden.
Uterine Fibroids
Affects 80% of Black women by age 50. Receives less than 0.5% of NIH gynecology funding.
Explore research →
Keloid Formation
Occurs at 15× higher rates in people of African descent. Virtually absent from major dermatology trials.
Hypertensive Kidney Disease
Leading cause of kidney failure in Black Americans — 3× the rate of white Americans.
Sickle Cell Complications
Affects 1 in 365 Black Americans. FDA-approved treatments trail other blood disorders by decades.